GlassScriptPhysician profile
Mohamed A Helal
NPI 1427012541
$2,899.65
in general payments reported to CMS, 2019-2025
36 companies · $25.30 in 2025
The $25.30 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $560 · 2021: $1,081 · 2022: $626 · 2023: $76.61 · 2025: $25.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $385.28 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $354.05 | 2019-2025 | Provenge |
| Abbvie INC. | $234.06 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $216.76 | 2019-2022 | |
| Astellas Pharma US INC | $188.04 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.19 | 2019-2021 | |
| Axonics, INC. | $138.18 | 2021 | |
| Travere Therapeutics, INC. | $126.74 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $119.37 | 2020-2022 | |
| Urovant Sciences INC | $84.27 | 2021-2022 | |
| Pfizer INC. | $68.01 | 2019-2022 | |
| Blue Earth Diagnostics | $65.13 | 2021-2022 | |
| Clarus Therapeutics INC. | $64.77 | 2021 | |
| Myovant Sciences INC. | $55.40 | 2021 | |
| Neotract INC. | $51.99 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $50.20 | 2022 | |
| Sun Pharmaceutical Industries INC. | $46.02 | 2019 | |
| Metuchen Pharmaceuticals | $38.59 | 2019-2020 | |
| Amgen INC. | $37.90 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $37.38 | 2021-2022 | |
| Boston Scientific Corporation | $37.01 | 2023 | Spaceoar Vue System - 10ml |
| Antares Pharma, INC. | $36.53 | 2019 | |
| Myriad Genetic Laboratories, INC. | $33.72 | 2022 | |
| Merck Sharp & Dohme LLC | $32.51 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $30.48 | 2020 | |
| Foundation Medicine, INC. | $29.07 | 2020 | |
| Allergan, INC. | $25.30 | 2021 | |
| Telix Pharmaceuticals | $22.94 | 2023 | Illuccix |
| Laborie Medical Technologies Corp. | $21.61 | 2022 | |
| Edap Technomed INC | $16.66 | 2023 | |
| Medtronic USA, INC. | $16.27 | 2019 | |
| Ambu INC. | $16.10 | 2021 | |
| Verity Pharmaceuticals INC. | $14.96 | 2022 | |
| Mission Pharmacal Company | $14.78 | 2021 | |
| Teleflex LLC | $12.35 | 2022 | |
| Medtronic, INC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Helal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.